The path well traveled: using mammalian retroviruses to guide research on XMRV.
Lee
KyeongEun
K
Model Development Section, HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, Maryland 21702, USA. joneska@mail.nih.gov
Jones
Kathryn S
KS
D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D015673:Fatigue Syndrome, Chronic / Q000821:virology; D005260:Female; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000821:virology; D012190:Retroviridae / Q000302:isolation & purification* / Q000472:pathogenicity* / Q000648:ultrastructure; D012192:Retroviridae Infections / Q000821:virology*; D014412:Tumor Virus Infections / Q000821:virology*
D044966:Anti-Retroviral Agents